» Articles » PMID: 12475634

Epidemiology of Visceral Leishmaniasis in Atbara River Area, Eastern Sudan: the Outbreak of Barbar El Fugara Village (1996-1997)

Overview
Journal Microbes Infect
Publisher Elsevier
Date 2002 Dec 12
PMID 12475634
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

An outbreak of visceral leishmaniasis (VL) started in 1995 in the Atbara River area in eastern Sudan. This article reports on this outbreak and on the clinical and immunological studies that were carried out in a village, with the highest incidence of VL cases, from 1996 to 1997. A significant increase in VL incidence was recorded in a dozen villages in this area; one village, Barbar El Fugara accounted for half of the total number of cases recorded at the regional hospital. A total of 152 VL and 61 post kala-azar dermal lesion (PKDL) cases were diagnosed and treated in Barbar. Household (n = 671) and school (n = 276) surveys were performed using the leishmanin skin test (LST) and the direct agglutination test (DAT). LST positivity was 23.1 and 15.7%, whereas DAT positivity was 8.9 and 26.4% in both surveys, respectively. No gender differences were observed in either test. Unlike DAT, LST positivity was predominant in the higher age groups that also exhibited lower prevalence of VL. Few individuals were positive by both tests (1.3%, 5.2%) while the majority (68.8%, 64.8%) had no evidence of acquired immune response, suggesting either a role of innate immunity in preventing parasite establishment or, unexpectedly, lack of exposure to Leishmania. Subclinical parasitism was also demonstrated, as evidence of both acquired humoral and cellular immune responses was observed in individuals with no past history of the disease. The wide spectrum of L. donovani/human interactions may be explained by differential exposure to environmental risk factors, parasite strain polymorphisms or host genetic makeup.

Citing Articles

Prevalence of human visceral leishmaniasis and its risk factors in Eastern Africa: a systematic review and meta-analysis.

Geto A, Berihun G, Berhanu L, Desye B, Daba C Front Public Health. 2024; 12():1488741.

PMID: 39659723 PMC: 11628699. DOI: 10.3389/fpubh.2024.1488741.


Prevalence of human leishmaniasis in Sudan: A systematic review and meta-analysis.

Ahmed M, Abdullah A, Bello I, Hamad S, Bashir A World J Methodol. 2022; 12(4):305-318.

PMID: 36159098 PMC: 9350725. DOI: 10.5662/wjm.v12.i4.305.


Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity.

Curtin J, Aronson N Microorganisms. 2021; 9(3).

PMID: 33799892 PMC: 7998217. DOI: 10.3390/microorganisms9030578.


Estimation of Leishmania spp. infection in asymptomatic people from Muzaffarpur, Bihar, India by antigen-antibody and skin testing.

Johanson G, Amato V, Ribeiro V, Tuon F Rev Inst Med Trop Sao Paulo. 2020; 62:e67.

PMID: 33027391 PMC: 7534399. DOI: 10.1590/S1678-9946202062067.


Prevalence of asymptomatic infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015.

Ibarra-Meneses A, Carrillo E, Nieto J, Sanchez C, Ortega S, Estirado A Euro Surveill. 2019; 24(22).

PMID: 31164191 PMC: 6549460. DOI: 10.2807/1560-7917.ES.2019.24.22.1800379.